Phase I/II trial of the CXCR4 inhibitor plerixafor in combination with bortezomib as a chemosensitization strategy in relapsed/refractory multiple myeloma
| Image |  |
|---|---|
| Description | scientific article published on 04 October 2019 |
| Author/s |
author: Abdel Kareem Azab Irene Ghobrial Kalvis Hornburg Rachid Baz Lorenzo Trippa |
| Publication date | October 4, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |